Antiepileptic and psychotropic drugs

Andreas J. Bircher; Knut Brockow

doi:10.1007/978-3-030-82743-4_29

Antiepileptic and psychotropic drugs

Andreas J. Bircher, Knut Brockow

Default

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

Abstract

According to the WHO [1], approximately 50 million adults and approximately ten million children [2] suffer from epilepsy worldwide; in the USA approximately three million adults and 0.5 million children are affected. In 40% of cases, epilepsy has an underlying central nervous system origin, whereas in 60% there is no identifiable cause. All patients with epilepsy require anticonvulsant therapy with antiepileptic drugs (AEDs) typically as long-term therapy, and approximately one-third require more than one AED; thus, a combination of two or more AEDs and permanent treatment is frequently required. Consequently, these drugs are used in patients with a wide age range from newborn to very old individuals, and treatment cannot be easily paused or changed.

Original language	English
Title of host publication	Cutaneous Drug Hypersensitivity
Subtitle of host publication	Clinical Features, Mechanisms, Diagnosis, and Management
Publisher	Springer International Publishing
Pages	257-266
Number of pages	10
ISBN (Electronic)	9783030827434
ISBN (Print)	9783030827427
DOIs	https://doi.org/10.1007/978-3-030-82743-4_29
State	Published - 9 Jul 2022

Access to Document

10.1007/978-3-030-82743-4_29

Cite this

@inbook{7b829c43c7ca4f9b87e08ba177ad294f,

title = "Antiepileptic and psychotropic drugs",

abstract = "According to the WHO [1], approximately 50 million adults and approximately ten million children [2] suffer from epilepsy worldwide; in the USA approximately three million adults and 0.5 million children are affected. In 40% of cases, epilepsy has an underlying central nervous system origin, whereas in 60% there is no identifiable cause. All patients with epilepsy require anticonvulsant therapy with antiepileptic drugs (AEDs) typically as long-term therapy, and approximately one-third require more than one AED; thus, a combination of two or more AEDs and permanent treatment is frequently required. Consequently, these drugs are used in patients with a wide age range from newborn to very old individuals, and treatment cannot be easily paused or changed.",

author = "Bircher, {Andreas J.} and Knut Brockow",

year = "2022",

month = jul,

day = "9",

doi = "10.1007/978-3-030-82743-4_29",

language = "English",

isbn = "9783030827427",

pages = "257--266",

booktitle = "Cutaneous Drug Hypersensitivity",

publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Antiepileptic and psychotropic drugs

AU - Bircher, Andreas J.

AU - Brockow, Knut

PY - 2022/7/9

Y1 - 2022/7/9

N2 - According to the WHO [1], approximately 50 million adults and approximately ten million children [2] suffer from epilepsy worldwide; in the USA approximately three million adults and 0.5 million children are affected. In 40% of cases, epilepsy has an underlying central nervous system origin, whereas in 60% there is no identifiable cause. All patients with epilepsy require anticonvulsant therapy with antiepileptic drugs (AEDs) typically as long-term therapy, and approximately one-third require more than one AED; thus, a combination of two or more AEDs and permanent treatment is frequently required. Consequently, these drugs are used in patients with a wide age range from newborn to very old individuals, and treatment cannot be easily paused or changed.

AB - According to the WHO [1], approximately 50 million adults and approximately ten million children [2] suffer from epilepsy worldwide; in the USA approximately three million adults and 0.5 million children are affected. In 40% of cases, epilepsy has an underlying central nervous system origin, whereas in 60% there is no identifiable cause. All patients with epilepsy require anticonvulsant therapy with antiepileptic drugs (AEDs) typically as long-term therapy, and approximately one-third require more than one AED; thus, a combination of two or more AEDs and permanent treatment is frequently required. Consequently, these drugs are used in patients with a wide age range from newborn to very old individuals, and treatment cannot be easily paused or changed.

UR - http://www.scopus.com/inward/record.url?scp=85154561949&partnerID=8YFLogxK

U2 - 10.1007/978-3-030-82743-4_29

DO - 10.1007/978-3-030-82743-4_29

M3 - Chapter

AN - SCOPUS:85154561949

SN - 9783030827427

SP - 257

EP - 266

BT - Cutaneous Drug Hypersensitivity

PB - Springer International Publishing

ER -

Antiepileptic and psychotropic drugs

Abstract

Access to Document

Other files and links

Fingerprint

Cite this